Company Overview of Funxional Therapeutics Ltd.
Funxional Therapeutics Ltd. discovers and develops anti-inflammatory therapies for respiratory disorders. Its product portfolio comprises FX125L, an orally available small molecule that acts as a broad spectrum chemokine inhibitor (BSCI); FX141L, a back-up compound for FX125L; and FX87L, a BSCI with biopharmaceutical characteristics that make it suitable for topical administration. The company was incorporated in 2005 and is based in Cambridge, the United Kingdom.
Cambridge, CB1 1BH
Founded in 2005
44 1223 451095
Key Executives for Funxional Therapeutics Ltd.
Similar Private Companies By Industry
|Atlantic Healthcare plc||Europe|
|Celltech Group Limited||Europe|
|PsiOxus Therapeutics, Ltd.||Europe|
|The Wellcome Foundation Limited||Europe|
|Eli Lilly and Company Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Funxional Therapeutics Ltd., please visit www.funxionaltherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.